ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 851

Does the Clinical Context Improve the Reliability of Rheumatologists Grading Digital Ulcers in Systemic Sclerosis?

Michael Hughes1, Chris Roberts2, Andrew Tracey1, Graham Dinsdale1, Andrea Murray1 and Ariane L. Herrick1, 1Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 2Centre for Biostatistics, Institute of Population Health, University of Manchester, Manchester, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: clinical trials, Outcome measures, Scleredema, systemic sclerosis and ulcers

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Digital
ulcers (DUs) are often a primary end point in SSc clinical trials, although the
reliability of rheumatologists grading DUs is poor to moderate at best. This is
of concern as DUs are often a primary outcome measure in SSc clinical trials.
DU assessment in recent trials has been based upon visual inspection alone,
which potentially misses ‘real-world’ clinical contextual information (e.g.
pain and discharge). Our aim was to investigate whether this clinical
information improves the reliability of rheumatologists grading DUs.

Methods:

80
photographs of a range of digital lesions were collected from patients with
SSc-spectrum disorders (mainly SSc). The following clinical information was
collected for each image:  duration of
the lesion (patient reported), pain associated with the lesion on a visual
analogue score (100 being most severe) and its temporal relationship (whether
the pain was less, the same or worse than a week ago), and the presence of
discharge (both patient reported and clinician observed). A custom web-based
interface was constructed to display the images and record the grading.
Rheumatologists were invited to participate through SSc-specialist networks and
were randomised to receive all images either with or without context. Lesions
were graded on an ordinal scale of severity: ‘no ulcer’, ‘inactive ulcer’ or
‘active ulcer’. Reliability was assessed using a weighted kappa coefficient,
with bootstrapping to generate estimates of confidence intervals. Ordinal
logistic regression was used to investigate the relationship  between the clinical context and
grading.

Results:

51
rheumatologists completed the study (25 with and 26 without context), from 15
countries (mainly the US, UK, Canada and Italy). A total of 4590 (4080 unique
and 510 repeated) image gradings were obtained. The intra and inter-rater
reliability both without and with the context is presented in Table 1. There
was no significant increase in the overall intra- or inter-rater reliability
with the clinical context. There was a trend towards an increase in intra-rater
reliability for ‘no ulcers’ vs. ‘inactive ulcers’ and ‘no ulcers’ vs.
‘inactive’/’active ulcers’, and a decrease for ‘inactive ulcers’ vs. ‘active
ulcers’. Patient reported discharge (OR= 2.67, 95% c.i. 2.02 to 3.53, P =
<0.001) and pain VAS (OR= 1.02, 95% c.i. 1.01 to 1.03, P = <0.001) were
associated with increased lesion severity, and lesion duration with reduced
severity (OR= 0.81, 95% c.i. 0.76 to 0.86, P = <0.001).

Conclusion:

1.
The overall intra and inter-rater reliability did not significantly improve
with added clinical context.

2.
There was a trend that clinicians may use the clinical context to help classify
lesions as ‘no ulcer’.

3.
Patient reported discharge and pain were associated with increased lesion
severity and duration with reduced severity.

Table 1: Intra- and inter-rater reliability without
and with context.

INTRA-RATER RELIABILITY

(95% CI)

INTER-RATER RELIABILITY

(95% CI)

Without context

With context

Without context

With context

Overall

0.64

(0.53, 0.75)

0.71

(0.64, 0.78)

0.32

(0.25, 0.39)

0.36

(0.28, 0.44)

Pairwise

No ulcers vs. inactive ulcers

0.36

(0.08,0.60)

0.67

(0.50,0.84)

-0.07

(-0.17,0.02)

-0.03

(-0.12,0.05)

No ulcers vs. active ulcers

0.95

(0.90,1.0)

0.90

(0.84,0.95)

0.42

(0.34,0.51)

0.44

(0.35,0.53)

Inactive vs. active ulcers

0.53

(0.38,0.67)

0.41

(0.22,0.60)

0.22

(0.14,0.30)

0.21

(0.12,0.30)

Dichotomised

No ulcers vs. inactive/active ulcers

0.71

(0.60, 0.81)

0.82

(0.75, 0.89)

0.22

(0.16, 0.27)

0.26

(0.21, 0.31)

No ulcers/inactive ulcers vs. active ulcers

0.74

(0.66, 0.82)

0.72

(0.65, 0.79)

0.32

(0.25, 0.39)

0.35

(0.27, 0.43)


Disclosure: M. Hughes, None; C. Roberts, None; A. Tracey, None; G. Dinsdale, None; A. Murray, None; A. L. Herrick, None.

To cite this abstract in AMA style:

Hughes M, Roberts C, Tracey A, Dinsdale G, Murray A, Herrick AL. Does the Clinical Context Improve the Reliability of Rheumatologists Grading Digital Ulcers in Systemic Sclerosis? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/does-the-clinical-context-improve-the-reliability-of-rheumatologists-grading-digital-ulcers-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-the-clinical-context-improve-the-reliability-of-rheumatologists-grading-digital-ulcers-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology